TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 46 filers reported holding TALIS BIOMEDICAL CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $21,741 | -26.2% | 45,294 | -24.7% | 0.00% | – |
| Q1 2023 | $29,459 | +9.9% | 60,120 | 0.0% | 0.00% | – |
| Q4 2022 | $26,814 | -34.6% | 60,120 | 0.0% | 0.00% | – |
| Q3 2022 | $41,000 | -16.3% | 60,120 | 0.0% | 0.00% | – |
| Q2 2022 | $49,000 | +345.5% | 60,120 | +666.9% | 0.00% | – |
| Q1 2022 | $11,000 | -68.6% | 7,839 | -10.7% | 0.00% | – |
| Q4 2021 | $35,000 | -62.8% | 8,781 | -41.5% | 0.00% | – |
| Q3 2021 | $94,000 | +5.6% | 15,007 | +85.9% | 0.00% | – |
| Q2 2021 | $89,000 | -16.8% | 8,072 | -3.2% | 0.00% | – |
| Q1 2021 | $107,000 | – | 8,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,235,783 | $1,073,176 | 0.05% |
| WELLS FARGO & COMPANY/MN | 174 | $84 | 0.00% |
| NORTHERN TRUST CORP | 27,860 | $13,373 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 140,530 | $67,454 | 0.00% |
| STATE STREET CORP | 47,436 | $22,769 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 91,463 | $43,902 | 0.00% |
| DEUTSCHE BANK AG\ | 45,294 | $21,741 | 0.00% |
| MORGAN STANLEY | 61,857 | $29,691 | 0.00% |
| BlackRock Inc. | 76,307 | $36,628 | 0.00% |